» Articles » PMID: 31423111

Hypoxia and HIF Activation As a Possible Link Between Sepsis and Thrombosis

Overview
Journal Thromb J
Publisher Biomed Central
Date 2019 Aug 20
PMID 31423111
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Risk factors for thrombosis include hypoxia and sepsis, but the mechanisms that control sepsis-induced thrombus formation are incompletely understood. A recent article published in Thrombosis Journal: (i) reviews the role of endothelial cells in the pathogenesis of sepsis-associated microthrombosis; (ii) describes a novel 'two-path unifying theory' of hemostatic discorders; and (iii) refers to hypoxia as a consequence of microthrombus formation in sepsis patients. The current article adds to this review by describing how sepsis and thrombus formation could be linked through hypoxia and activation of hypoxia-inducible transcription factors (HIFs). In other words, hypoxia and HIF activation may be a cause as well as a consequence of thrombosis in sepsis patients. While microthrombosis reduces microvascular blood flow causing local hypoxia and tissue ischemia, sepsis-induced increases in HIF1 activation could conversely increase the expression of coagulant factors and integrins that promote thrombus formation, and stimulate the formation of pro-thrombotic neutrophil extracellular traps. A better understanding of the role of cell-specific HIFs in thrombus formation could lead to the development of novel prophylactic therapies for individuals at risk of thrombosis.

Citing Articles

Post-pandemic insights on COVID-19 and premature ovarian insufficiency.

Han Y, Dai Y, Wang K, Zhang X, Shao Z, Zhu X Open Life Sci. 2025; 20(1):20221028.

PMID: 39886482 PMC: 11780258. DOI: 10.1515/biol-2022-1028.


From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction.

Srdic T, durasevic S, Lakic I, Ruzicic A, Vujovic P, Jevdovic T Int J Mol Sci. 2024; 25(14).

PMID: 39063011 PMC: 11277140. DOI: 10.3390/ijms25147770.


eQTLs identify regulatory networks and drivers of variation in the individual response to sepsis.

Burnham K, Milind N, Lee W, Kwok A, Cano-Gamez K, Mi Y Cell Genom. 2024; 4(7):100587.

PMID: 38897207 PMC: 11293594. DOI: 10.1016/j.xgen.2024.100587.


The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Locatelli F, Del Vecchio L, Elliott S Clin Kidney J. 2023; 16(10):1563-1579.

PMID: 37779852 PMC: 10539216. DOI: 10.1093/ckj/sfad105.


Agonal Thrombus at Necropsy-A Third Category of Blood Coagulation in Domestic Carnivores.

Tiu R, Rizac R, Nicolae G, Turbatu R, Ciobotaru-Pirvu E Life (Basel). 2023; 13(9).

PMID: 37763238 PMC: 10532760. DOI: 10.3390/life13091834.


References
1.
Yan S, Mackman N, Kisiel W, STERN D, Pinsky D . Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol. 1999; 19(9):2029-35. DOI: 10.1161/01.atv.19.9.2029. View

2.
Walton H, Corjay M, Mohamed S, Mousa S, Santomenna L, Reilly T . Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells. J Cell Biochem. 2000; 78(4):674-80. DOI: 10.1002/1097-4644(20000915)78:4<674::aid-jcb16>3.0.co;2-g. View

3.
Liu X, Schnellmann R . Calpain mediates progressive plasma membrane permeability and proteolysis of cytoskeleton-associated paxillin, talin, and vinculin during renal cell death. J Pharmacol Exp Ther. 2002; 304(1):63-70. DOI: 10.1124/jpet.102.043406. View

4.
Fowkes F, Price J, Fowkes F . Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003; 25(1):1-5. DOI: 10.1053/ejvs.2002.1778. View

5.
Rectenwald J, Wakefield T . The treatment of deep venous thrombosis, including the newer agents. Dis Mon. 2005; 51(2-3):104-11. DOI: 10.1016/j.disamonth.2005.03.004. View